Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Peptide Vaccination Against Cytomegalovirus (CMV) Elicits Immunological and Clinical Responses after Allogeneic Stem Cell Transplantation Even from a CMV Seronegative Donor

Blood (2016) 128 (22): 2519.

https://doi.org/10.1182/blood.V128.22.2519.2519

Published: 2016

Journal Articles

B- Cell Depletion as Therapy for Steroid Refractory Chronic Gvhd Is Most Effective for Sclerosis of the Skin.

Suzanne van Dorp, MD, Henk Lokhorst, MD, PhD, Eefke Petersen, MD, PhD, Monique C. Minnema, MD, PhD, Lambert F. Span, MD, PhD, Saskia Ebeling, PhD, Marijke van Dijk, MD, PhD, Ellen Meijer, MD, PhD, Juergen Kuball, MD, PhD

Blood (2009) 114 (22): 2232.

https://doi.org/10.1182/blood.V114.22.2232.2232

Published: 2009

Journal Articles

Improving Tumor Immunotherapy by Using Distinct Subpopulations of the γδT Cell Repertoire with High Anti-Tumor Reactivity.

Suzanne van Dorp, MD, Samantha Hol, Victoria Marcu-Malina, PhD, Nicole Thuss, Henk Lokhorst, MD, PhD, Juergen Kuball, MD, PhD

Blood (2009) 114 (22): 4504.

https://doi.org/10.1182/blood.V114.22.4504.4504

Published: 2009

Journal Articles

Playing the Game Together: Coexpression of a Single Chain T Cell Receptor and a T Cell Receptor Constant-Alpha Domain Triggers Tumor Reactivity.

Simone Thomas, MD, Ralf H. Voss, PhD, Ratna Intan, Renate Engel, Juergen Kuball, MD, Christoph Huber, MD, Matthias Theobald, MD

Blood (2006) 108 (11): 3716.

https://doi.org/10.1182/blood.V108.11.3716.3716

Published: 2006

Journal Articles

Vaccination with WT1 and PR3 Derived Peptides in Patients with AML/MDS and MUC1 Peptides in Patients with Multiple Myeloma - Preliminary Results.

Eva M. Wagner, Juergen Kuball, MD, Mohamed Wattad, MD, Christoph Huber, MD, Wolfgang Heit, MD, Matthias Theobald, MD

Blood (2006) 108 (11): 4582.

https://doi.org/10.1182/blood.V108.11.4582.4582

Published: 2006

NARROW

Peptide Vaccination Against Cytomegalovirus (CMV) Elicits Immunological and Clinical Responses after Allogeneic Stem Cell Transplantation Even from a CMV Seronegative Donor

B- Cell Depletion as Therapy for Steroid Refractory Chronic Gvhd Is Most Effective for Sclerosis of the Skin.

Improving Tumor Immunotherapy by Using Distinct Subpopulations of the γδT Cell Repertoire with High Anti-Tumor Reactivity.

Playing the Game Together: Coexpression of a Single Chain T Cell Receptor and a T Cell Receptor Constant-Alpha Domain Triggers Tumor Reactivity.

Vaccination with WT1 and PR3 Derived Peptides in Patients with AML/MDS and MUC1 Peptides in Patients with Multiple Myeloma - Preliminary Results.

Email alerts

ASH Publications

American Society of Hematology

Peptide Vaccination Against Cytomegalovirus (CMV) Elicits Immunological and Clinical Responses after Allogeneic Stem Cell Transplantation Even from a CMV Seronegative Donor

B- Cell Depletion as Therapy for Steroid Refractory Chronic Gvhd Is Most Effective for Sclerosis of the Skin.

Improving Tumor Immunotherapy by Using Distinct Subpopulations of the γδT Cell Repertoire with High Anti-Tumor Reactivity.

Playing the Game Together: Coexpression of a Single Chain T Cell Receptor and a T Cell Receptor Constant-Alpha Domain Triggers Tumor Reactivity.

Vaccination with WT1 and PR3 Derived Peptides in Patients with AML/MDS and MUC1 Peptides in Patients with Multiple Myeloma - Preliminary Results.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only